Semaglutide's most common side effects are gastrointestinal; proper clinician oversight and titration reduce risk.
Semaglutide's most common side effects are gastrointestinal — nausea, vomiting, diarrhea, constipation — usually managed by gradual titration. Compounded semaglutide is not an FDA-approved finished product, so clinician oversight, a verifiable pharmacy, and honest sourcing matter for safety. Some patients should not take GLP-1 medications; a licensed clinician should evaluate you.
Most side effects are gastrointestinal and tend to ease as the body adjusts during titration. Report severe or persistent symptoms to your clinician.
Use a licensed prescriber, a named verifiable pharmacy, temperature-controlled shipping, and proper titration. Avoid research-labeled products.
With proper clinician oversight and a verifiable licensed pharmacy, many patients use it, but Compounded semaglutide is not an FDA-approved finished drug product and is not the same as Ozempic® or Wegovy®. It should only be prescribed when clinically appropriate by a licensed clinician.
Most commonly gastrointestinal — nausea, vomiting, diarrhea, constipation — usually managed with titration.
People with certain conditions should avoid GLP-1 medications; a licensed clinician should evaluate eligibility.
Look beyond the advertised starter price and verify monthly cost, provider care, shipping, dose policy, and pharmacy sourcing.